Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Smith

Showing results (61-70 of 238) with videos related to

Pageof 24
Sort By:
Aviation, Space, and Environmental Medicine|March 1, 1993
Retroperitoneal fibrosis as a cause of hypertension in an aviator: a case reportL H Smith, R S Broadhurst
The Western Journal of Medicine|October 1, 1982
Thoughts on the Past, Present and Future of WJMM S Watts, L H Smith
Biotechnology and Bioengineering|August 20, 1997
Laboratory evaluation of a two-stage treatment system for TCE cometabolism by a methane-oxidizing mixed cultureL H Smith, P L McCarty
Laboratory Animal Science|February 1, 1975
A normobaric hypoxia facility for preparing polycythemic mice for assay of erythropoietinC W Hancher, L H Smith
Journal of Medicinal Chemistry|February 1, 1980
Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanolsM S Large, L H Smith
Journal of Molecular Biology|June 5, 1976
The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weightsL H Smith, R L Sinsheimer
Obstetrical & Gynecological Survey|June 1, 1984
Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigensL H Smith, R H Oi
Journal of Medicinal Chemistry|March 1, 1983
beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-olsM S Large, L H Smith
Cancer|October 15, 1987
Clinical applications of monoclonal antibodies in gynecologic oncologyL H Smith, N N Teng
Science (New York, N.Y.)|January 29, 1971
Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanismH E Williams, L H Smith
Pageof 24

Showing results (61-70 of 238) with videos related to

Sort By:
Pageof 24
Aviation, Space, and Environmental Medicine|March 1, 1993
Retroperitoneal fibrosis as a cause of hypertension in an aviator: a case reportL H Smith, R S Broadhurst
The Western Journal of Medicine|October 1, 1982
Thoughts on the Past, Present and Future of WJMM S Watts, L H Smith
Biotechnology and Bioengineering|August 20, 1997
Laboratory evaluation of a two-stage treatment system for TCE cometabolism by a methane-oxidizing mixed cultureL H Smith, P L McCarty
Laboratory Animal Science|February 1, 1975
A normobaric hypoxia facility for preparing polycythemic mice for assay of erythropoietinC W Hancher, L H Smith
Journal of Medicinal Chemistry|February 1, 1980
Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanolsM S Large, L H Smith
Journal of Molecular Biology|June 5, 1976
The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weightsL H Smith, R L Sinsheimer
Obstetrical & Gynecological Survey|June 1, 1984
Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigensL H Smith, R H Oi
Journal of Medicinal Chemistry|March 1, 1983
beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-olsM S Large, L H Smith
Cancer|October 15, 1987
Clinical applications of monoclonal antibodies in gynecologic oncologyL H Smith, N N Teng
Science (New York, N.Y.)|January 29, 1971
Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanismH E Williams, L H Smith
Pageof 24